182 related articles for article (PubMed ID: 25989890)
1. Relationship between ABCB1 gene polymorphisms and severe neutropenia in patients with breast cancer treated with doxorubicin/cyclophosphamide chemotherapy.
Ikeda M; Tsuji D; Yamamoto K; Kim YI; Daimon T; Iwabe Y; Hatori M; Makuta R; Hayashi H; Inoue K; Nakamichi H; Shiokawa M; Itoh K
Drug Metab Pharmacokinet; 2015 Apr; 30(2):149-53. PubMed ID: 25989890
[TBL] [Abstract][Full Text] [Related]
2. Drug-related genetic polymorphisms affecting severe chemotherapy-induced neutropenia in breast cancer patients: A hospital-based observational study.
Tsuji D; Ikeda M; Yamamoto K; Nakamori H; Kim YI; Kawasaki Y; Otake A; Yokoi M; Inoue K; Hirai K; Nakamichi H; Tokou U; Shiokawa M; Itoh K
Medicine (Baltimore); 2016 Nov; 95(44):e5151. PubMed ID: 27858847
[TBL] [Abstract][Full Text] [Related]
3. ABCB1 polymorphism as prognostic factor in breast cancer patients treated with docetaxel and doxorubicin neoadjuvant chemotherapy.
Kim HJ; Im SA; Keam B; Ham HS; Lee KH; Kim TY; Kim YJ; Oh DY; Kim JH; Han W; Jang IJ; Kim TY; Park IA; Noh DY
Cancer Sci; 2015 Jan; 106(1):86-93. PubMed ID: 25410489
[TBL] [Abstract][Full Text] [Related]
4. Prospective evaluation of the drug-metabolizing enzyme polymorphisms and toxicity profile of docetaxel in Korean patients with operable lymph node-positive breast cancer receiving adjuvant chemotherapy.
Kim KP; Ahn JH; Kim SB; Jung KH; Yoon DH; Lee JS; Ahn SH
Cancer Chemother Pharmacol; 2012 May; 69(5):1221-7. PubMed ID: 22271208
[TBL] [Abstract][Full Text] [Related]
5. Association of ABCB1 polymorphisms with the antiemetic efficacy of granisetron plus dexamethasone in breast cancer patients.
Tsuji D; Kim YI; Nakamichi H; Daimon T; Suwa K; Iwabe Y; Hayashi H; Inoue K; Yoshida M; Itoh K
Drug Metab Pharmacokinet; 2013; 28(4):299-304. PubMed ID: 23358260
[TBL] [Abstract][Full Text] [Related]
6. Analysis of pharmacogenomic factors for chemotherapy-induced nausea and vomiting in patients with breast cancer receiving doxorubicin and cyclophosphamide chemotherapy.
Tsuji D; Matsumoto M; Kawasaki Y; Kim YL; Yamamoto K; Nakamichi H; Sahara Y; Makuta R; Yokoi M; Miyagi T; Itoh K
Cancer Chemother Pharmacol; 2021 Jan; 87(1):73-83. PubMed ID: 33099677
[TBL] [Abstract][Full Text] [Related]
7. Association of ABCB1 and SLC22A16 Gene Polymorphisms with Incidence of Doxorubicin-Induced Febrile Neutropenia: A Survey of Iranian Breast Cancer Patients.
Faraji A; Dehghan Manshadi HR; Mobaraki M; Zare M; Houshmand M
PLoS One; 2016; 11(12):e0168519. PubMed ID: 28036387
[TBL] [Abstract][Full Text] [Related]
8. Side effects after docetaxel treatment in Taiwanese breast cancer patients with CYP3A4, CYP3A5, and ABCB1 gene polymorphisms.
Tsai SM; Lin CY; Wu SH; Hou LA; Ma H; Tsai LY; Hou MF
Clin Chim Acta; 2009 Jun; 404(2):160-5. PubMed ID: 19332043
[TBL] [Abstract][Full Text] [Related]
9. ABCB1 and ABCC2 genetic polymorphism as risk factors for neutropenia in esophageal cancer patients treated with docetaxel, cisplatin, and 5-fluorouracil chemotherapy.
Nomura H; Tsuji D; Demachi K; Mochizuki N; Matsuzawa H; Yano T; Daiko H; Fujii S; Kojima T; Itoh K; Kawasaki T
Cancer Chemother Pharmacol; 2020 Aug; 86(2):315-324. PubMed ID: 32748110
[TBL] [Abstract][Full Text] [Related]
10. Influence of pharmacogenetics on response and toxicity in breast cancer patients treated with doxorubicin and cyclophosphamide.
Bray J; Sludden J; Griffin MJ; Cole M; Verrill M; Jamieson D; Boddy AV
Br J Cancer; 2010 Mar; 102(6):1003-9. PubMed ID: 20179710
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetic association of MBL2 and CD95 polymorphisms with grade 3 infection following adjuvant therapy for breast cancer with doxorubicin and cyclophosphamide.
Jamieson D; Sunter N; Muro S; Pouché L; Cresti N; Lee J; Sludden J; Griffin MJ; Allan JM; Verrill MW; Boddy AV
Eur J Cancer; 2017 Jan; 71():15-24. PubMed ID: 27940354
[TBL] [Abstract][Full Text] [Related]
12. Influence of (C1236T and C3435T) Polymorphisms of ABCB1 Gene on Chemotherapy Treatment Outcome and Toxicity in Breast Cancer Patients.
Gudur RA; Bhosale SJ; Gudur AK; Kale SR; More AL; Datkhile KD
Asian Pac J Cancer Prev; 2024 May; 25(5):1567-1577. PubMed ID: 38809628
[TBL] [Abstract][Full Text] [Related]
13. Association of the ABCB1 gene polymorphisms 2677G>T/A and 3435C>T with clinical outcomes of paclitaxel monotherapy in metastatic breast cancer patients.
Chang H; Rha SY; Jeung HC; Im CK; Ahn JB; Kwon WS; Yoo NC; Roh JK; Chung HC
Ann Oncol; 2009 Feb; 20(2):272-7. PubMed ID: 18836089
[TBL] [Abstract][Full Text] [Related]
14. Study of ABCB1 polymorphism frequency in breast cancer patients from Poland.
Rubiś B; Hołysz H; Barczak W; Gryczka R; Łaciński M; Jagielski P; Czernikiewicz A; Półrolniczak A; Wojewoda A; Perz K; Białek P; Morze K; Kanduła Z; Lisiak N; Mrozikiewicz PM; Grodecka-Gazdecka S; Rybczyńska M
Pharmacol Rep; 2012; 64(6):1560-6. PubMed ID: 23406767
[TBL] [Abstract][Full Text] [Related]
15. Effects of ABCB1 and ABCG2 polymorphisms on the pharmacokinetics of abemaciclib.
Maeda A; Ando H; Irie K; Hashimoto N; Morishige JI; Fukushima S; Okada A; Ebi H; Matsuzaki M; Iwata H; Sawaki M
Eur J Clin Pharmacol; 2022 Aug; 78(8):1239-1247. PubMed ID: 35527301
[TBL] [Abstract][Full Text] [Related]
16. Influence of ABCB1 and ABCG2 polymorphisms on doxorubicin disposition in Asian breast cancer patients.
Lal S; Wong ZW; Sandanaraj E; Xiang X; Ang PC; Lee EJ; Chowbay B
Cancer Sci; 2008 Apr; 99(4):816-23. PubMed ID: 18377430
[TBL] [Abstract][Full Text] [Related]
17. Unrecognized renal insufficiency and chemotherapy-associated adverse effects among breast cancer patients.
Lotan E; Leader A; Lishner M; Gottfried M; Pereg D
Anticancer Drugs; 2012 Oct; 23(9):991-5. PubMed ID: 22728764
[TBL] [Abstract][Full Text] [Related]
18. Docetaxel/doxorubicin/cyclophosphamide in the treatment of metastatic breast cancer.
Nabholtz JM; Smylie M; Mackey J; Paterson A; Noel D; al-Tweigeri ; Janowska A; Delorme F; Riva A
Oncology (Williston Park); 1997 Jun; 11(6 Suppl 6):25-7. PubMed ID: 9213324
[TBL] [Abstract][Full Text] [Related]
19. ABCB1 polymorphisms associated with osteonecrosis of the femeral head.
Zhang Z; Li Y; Liu H; Shi J; Li X; Jiang W
Int J Clin Exp Pathol; 2015; 8(11):15240-4. PubMed ID: 26823873
[TBL] [Abstract][Full Text] [Related]
20. Clinical utility of ABCB1 and ABCG2 genotyping for assessing the clinical and pathological response to FAC therapy in Mexican breast cancer patients.
Turiján-Espinoza E; Ruíz-Rodríguez VM; Uresti-Rivera EE; Martínez-Leija E; Zermeño-Nava JJ; Guel-Pañola A; Romano-Moreno S; Vargas-Morales JM; Portales-Pérez DP
Cancer Chemother Pharmacol; 2021 Jun; 87(6):843-853. PubMed ID: 33740100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
